APA (7th ed.) Citation

Novartis Foundation. (2008). Defining optimal immunotherapies for type 1 diabetes. Wiley-Blackwell.

Chicago Style (17th ed.) Citation

Novartis Foundation. Defining Optimal Immunotherapies for Type 1 Diabetes. Chichester, U.K. ; Hoboken, N.J.: Wiley-Blackwell, 2008.

MLA (9th ed.) Citation

Novartis Foundation. Defining Optimal Immunotherapies for Type 1 Diabetes. Wiley-Blackwell, 2008.